Ratio Therapeutics entered today into an exclusive worldwide license and collaboration agreement with Novartis (NVS) Pharma AG, a subsidiary of ...

Ratio to receive upfront, and potential milestones and tiered royalty payments BOSTON, Nov. 18, 2024 /PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical ...

The U.S. patient population for Revuforj in its approved indication is roughly 2,000 according to Syndax. KMT2A leukemias ...

Keymed Biosciences has licensed global rights for CM336, excluding Greater China, to Platina Medicines in a deal worth up to ...

AUSTIN, Texas, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA), a clinical-stage biotechnology company focused on developing a novel treatment for Alzheimer’s ...

Ratio Therapeutics Inc. Monday announced partnership with Novartis Pharma AG, a unit of Novartis AG (NVS) to develop a ...

Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class ...

The US Food and Drug Administration (FDA) has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating relapsed or ...

President-Elect Donald Trump has nominated antivaccine activist and anti-pharma conspiracy theorist Robert F. Kennedy, Jr. to be Secretary of Health and Human Services. I've written about the damage h ...

Royalty payments made by Indian listed companies to their related parties (RPs) have more than doubled in the last decade, rising from INR 4,955 crore in FY14 to INR 10,779 crore in FY23, according to ...

UBS has recently reduced Royalty Pharma plc (RPRX) stock to Neutral rating, as announced on June 3, 2024, according to Finviz. Earlier, on June 14, 2022, UBS had resumed the stock to Buy, setting a ...

Metalla Royalty & Streaming Ltd. (NYSEMKT:MTA – Free Report) – Equities researchers at National Bank Financial raised their FY2026 EPS estimates for shares of Metalla Royalty & Streaming in a note ...